ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,101Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 229

$436K Total Retail Price of All Prescriptions

Rank: 61 out of 229

851 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 851 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 851 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,088 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 586 537 1 1
SIMVASTATIN 555 501 2 3
LISINOPRIL 490 452 3 2
AMLODIPINE BESYLATE 371 351 4 5
HYDROCHLOROTHIAZIDE 272 266 5 9
LOVASTATIN 250 248 6 11
OMEPRAZOLE 229 205 7 4
METFORMIN HCL 211 175 8 6
HYDROCODONE-ACETAMINOPHEN 205 193 S3 9 7
METOPROLOL SUCCINATE 187 183 10 16
ATENOLOL 185 173 11 19
WARFARIN SODIUM 164 164 12 17
FUROSEMIDE 164 148 12 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 159 145 14 28
GABAPENTIN 139 94 15 10
FLUTICASONE PROPIONATE 136 106 16 23
ALLOPURINOL 131 127 17 27
TAMSULOSIN HCL 113 113 18 24
ALENDRONATE SODIUM 112 106 19 14
ZOLPIDEM TARTRATE 110 102 20 20
RANITIDINE HCL 104 85 21 32
FLUOXETINE HCL 103 81 22 41
TRAMADOL HCL 98 88 23 26
PANTOPRAZOLE SODIUM 82 81 24 33
OXYCODONE HCL 80 38 S2 25 37
CITALOPRAM HBR 74 73 26 21
POTASSIUM CHLORIDE 73 66 27 18
METOPROLOL TARTRATE 72 71 28 13
DOXAZOSIN MESYLATE 69 58 29 50
SERTRALINE HCL 67 66 30 22
DIOVAN 67 53 30 42
PRAVASTATIN SODIUM 67 65 30 25
CLONIDINE HCL 65 55 33 69
PAROXETINE HCL 62 59 34 49
PREDNISONE 61 57 35 35
LOSARTAN POTASSIUM 60 60 36 12
DONEPEZIL HCL 60 60 36 29
PROAIR HFA 56 38 38 38
GLYBURIDE 56 46 R 38 57
LOSARTAN-HYDROCHLOROTHIAZIDE 53 51 40 65
TRIAMCINOLONE ACETONIDE 53 50 40 113
CARVEDILOL 51 41 42 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.